FDA to get $7 million more than Obama requested
This article was originally published in The Silver Sheet
The House-Senate conference committee approved a bill Sept. 30 to fund FDA through fiscal 2010, including $2.36 billion in appropriations. The total is $306 million more than 2009 funding and $7 million more than President Obama requested. The bill also approves the collection of $893 million in industry user fees. Medical device activities will get $349.3 million in appropriations under the bill, plus $57 million in user fees. The conference agreement still needs approval by the full House and Senate, as well as the president's signature. The agency will be funded at fiscal 2009 levels though Oct. 31 under an existing continuing resolution
You may also be interested in...
House and Senate Democrats sponsor legislation to authorize FTC enforcement against sales of "consumer goods and services at an unconscionably excessive price during the" COVID-19 pandemic. "It’s outrageous that some companies and individuals are taking advantage of consumers by price-gouging," says Energy and Commerce Committee Chairman Frank Pallone.
Robert Califf, a former FDA commissioner turned Verily Life Sciences exec, is just one of the voice predicting a long-term impact on clinical trial processes from the COVID-19 outbreak.
A US National Academies meeting on digital health technology showcased the communication gap between regulators and tech developers when it comes to important concepts like “digital biomarkers.”